3-((BUTYLAMINO)METHYLENE)-1H-1,5-BENZODIAZEPINE-2,4(3H,5H)-DIONE
UNII QS03WS73M5

Substance Identification & Data

This profile provides standardized clinical and technical data for 3-((butylamino)methylene)-1h-1,5-benzodiazepine-2,4(3h,5h)-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QS03WS73M5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 81225-96-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

QS03WS73M5

CAS Registry Number

81225-96-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

3-((BUTYLAMINO)METHYLENE)-1H-1,5-BENZODIAZEPINE-2,4(3H,5H)-DIONE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C14H17N3O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

XJFLBWXJPVBIRE-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

342060

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1(C(Nc2ccccc2NC1=O)=O)=CNCCCC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 3-((butylamino)methylene)-1h-1,5-benzodiazepine-2,4(3h,5h)-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.